Cat on a Hot Twin Proof? After Cougar, Puma Roars
By Randy Osborne
Monday, October 22, 2012
Puma Biotechnology Inc.'s CEO Alan Auerbach first became widely known in 2009 for the sale of his previous firm, Cougar Biotechnology Inc., to Johnson & Johnson for $970 million, based largely on the strength of Cougar's lead compound, abiraterone.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.